Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is displayed, replacing v3.3.3. There are no visible changes to the study content or core details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:54:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A dedicated Locations section and listed sites (Kansas, Pennsylvania, Texas, Washington) were added, reorganizing location information for the study.
    Difference
    0.5%
    Check dated 2025-12-23T21:24:37.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Page revision history updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:32:27.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The general funding/operating status notice was removed, while the study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:48.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The new screenshot shows only formatting and UI adjustments; core study details (title, conditions, inclusion/exclusion criteria, interventions, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:39:40.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Introducing a major version upgrade to v3.2.0 and a government operating-status notice; removing the previous v3.1.0 reference. This indicates a new release with potentially updated functionality and critical status information for users.
    Difference
    3%
    Check dated 2025-10-06T04:50:15.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.